ValiRx launches new interactive investor website
ValiRx launches interactive investor website with Q&A portal for shareholders and stakeholders.
Select text to share a quote on X · sign in to keep highlights & notes in your VAL notes
ValiRx, a life science company focusing on early-stage cancer therapeutics and women's health, is pleased to announce the launch of our interactive investor website.
For both existing and prospective shareholders, the new investor hub brings all ValiRx content into a single integrated platform to better inform and engage with investors and stakeholders, including:
- Regulatory announcements
- Reports
- Presentations
- Educational material
- Interviews
- Corporate research
The investor hub also provides an interactive online experience allowing ValiRx stakeholders to comment on and ask the ValiRx team questions via a portal which will be monitored and responded to in a timely manner.
The Company's AIM Rule 26 website address and all information required by AIM Rule 26 remains unchanged.
How to sign up for the ValiRx investor hub:
- Visit www.valirx.com
- Follow the prompts to sign up for an investor hub account
- Complete your account profile
Mark Eccleston, CEO, commented:
"As a life sciences company focused on advancing cutting-edge therapies, it is essential that we keep our shareholders informed and engaged throughout our journey. InvestorHub enables us to identify and understand our investor base more clearly, allowing us to tailor communications that highlight key milestones, clinical developments, and the value of our progress. This ensures our shareholders remain aligned with our mission to deliver innovative solutions in healthcare."
The Directors are responsible for the release of this announcement.
| Investor questions on this announcement We encourage all investors to share questions on this announcement via our investor hub | https://valirx.com/link/vPn48e |
| ValiRx plc Dr Mark Eccleston, CEO | Tel: +44 (0) 2476 796496 www.valirx.com Mark.Eccleston@valirx.com |
| Shard Capital Partners LLP (Sole Broker) Damon Heath | Tel: +44 (0) 20 7186 9000 |
| V Formation (Public Relations) Lucy Wharton - Senior PR Executive Sue Carr - Director | +44 (0) 115 787 0206 www.vformation.biz lucy@vformation.biz sue@vformation.biz |
Subscribe to our news alert service: https://valirx.com/s/f298d1
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.